About James

Dr James Shi, is the senior advisor of Xiamen Innovax Biotech Co. Ltd., China. Over more than 20 years he has been the Senior and Principle Investigator, Laboratory Study Subsection Chief and Transfusion Transmitted Viruses Laboratory Supervisor, Infectious Diseases Section, Department of Transfusion Medicine, Warren Grant Magnuson Clinical Center,  National Institutes of Health in the US. Most recently he served as Professor in Microbiology, college of science and School of Public Health respectively in Xiamen University for over 10 years.

His research interests include viral hepatitis and infectious diseases diagnostics and vaccine development. He has over 170 peer reviewed papers on hepatitis E related publications. He holds a B.S. from Chung-Hsing University, Taiwan, China and a Ph.D. in Microbiology, from Vanderbilt University, Nashville, Tennessee.

This speaker will be presenting at the following session(s)

  • End of viral hepatitis? Not without tackling hepatitis E!

    Side meeting

    Day: 2 November

    Time: 07:30

    This early morning side meeting will look at this neglected virus and the limited strategies to control and key challenges/opportunities around it With no no efficacious treatment available for acute fulminant hepatitis E and the limited impact of improvements on safe water and sanitation access in displaced populations, this meeting will examine what can be done to limit the burden worldwide. 

    Presentations:

    • Introduction: Hepatitis E in humanitarian settings.
      Iza Ciglenecki,‎ Médecins Sans Frontières (MSF)
    • Hepatitis E in developing countries: an old disease?
      Dr. Rakesh Aggarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences
    • Hepatitis E in developed countries: a new disease?
      Harry Dalton, Royal Cornwell Hospitals NHS Trust
    • Hepatitis E vaccine: a new control tool?
      Dr. James Shih, Innovax
    • Round table discussion.
      Moderator: Harry Dalton, Royal Cornwell Hospitals NHS Trust